Dr. Federico Venturi is a board-certified dermatologist and current PhD candidate in Oncology, Hematology, and Pathology at the University of Bologna, where he also serves as a consultant at the Oncologic Dermatology Unit, IRCCS Policlinico Sant’Orsola. His clinical and research interests span skin cancer diagnostics, non-invasive imaging (dermoscopy, reflectance confocal microscopy), Mohs surgery, and molecular biomarkers—particularly microRNAs in melanoma. Dr. Venturi has authored over 75 peer-reviewed publications and presented extensively at national and international congresses. He is actively involved in several international scientific societies, including EADV, EADO, IDS, and the EORTC Melanoma Group, and has been awarded multiple national and international scholarships for his research. Dr. Venturi is also engaged in academic teaching and mentoring, and committed to translational dermatology and collaborative academic work across Europe and beyond.

Dr. Carlo Ronsini is an Italian gynecologic oncologist and surgeon currently serving as Head Physician of Gynecologic Oncology at the National Cancer Institute IRCCS Pascale Foundation in Naples, Italy. He completed his medical degree with highest honors at Università Cattolica del Sacro Cuore, Rome, and specialized in Gynecology and Obstetrics at G. d’Annunzio University, Chieti-Pescara. He holds advanced qualifications in minimally invasive gynecologic surgery and statistical methods for clinical research, and has been awarded National Scientific Qualification as Associate Professor in Gynecology and Obstetrics. His research focuses on endometrial and ovarian cancers, fertility preservation, and innovative surgical and therapeutic techniques such as HIPEC and robotic surgery. Dr. Ronsini has authored over 90 scientific publications, participated in major European conferences, and contributes actively to research networks in gynecologic oncology. His work emphasizes improving oncological outcomes and surgical precision in women’s reproductive health.

Dr. Sheila Spada is a translational researcher at the Tumor Immunology and Immunotherapy Unit of the Regina Elena National Cancer Institute in Rome, Italy. She obtained her Ph.D. in Immunology and Immunopathology from Sapienza University of Rome and completed multiple postdoctoral appointments at Weill Cornell Medicine, New York, focusing on tumor immunology and immune microenvironment modulation.Her research explores the role of extracellular vesicles, epigenetic regulation, and immune escape in cancer progression, aiming to develop innovative immunotherapy strategies. Dr. Spada serves as an editor and guest editor for several international journals, including Frontiers in Immunology and Cancer Immunology, Immunotherapy, and has published extensively in high-impact journals. She is a member of several international cancer research societies and a recipient of multiple grants and awards recognizing her contributions to the field of translational oncology.

Dr. Rita Marina Niespolo is a senior radiation oncologist at IRCCS San Gerardo dei Tintori in Monza, Italy, where she has worked since 2001. A recognized leader in stereotactic and image-guided radiotherapy, she serves as Vice-Clinical Director of the Radiotherapy Department and Coordinator of the AIRO Gastrointestinal Study Group. Her research focuses on stereotactic body radiotherapy, radiomics, and innovative treatment strategies for gastrointestinal malignancies. She has authored over 50 peer-reviewed articles and serves as reviewer for several prestigious international journals. Dr. Niespolo is also an experienced educator at the University of Milano-Bicocca, mentoring students and specialization residents in radiation oncology. Her career is distinguished by a strong commitment to clinical excellence, scientific collaboration, and continuous innovation in cancer care.